Many people believe that eczema mainly occurs in childhood and is likely to clear up as a child grows older. However, this itchy skin condition sometimes takes a heavier toll on adults than children, an expert says.
According to a Health24 article, eczema is a chronic skin disease caused by inflammation of the skin and its inability to retain adequate moisture.
The result is a dry and very troublesome rash and intense itching, which may occur on almost any part of the body.
‘It’s not just eczema’
“Adult eczema patients may have dealt with their symptoms for their entire lives, which can be draining, or they may experience symptoms for the first time as adults, which can be a difficult adjustment,” said Dr Jonathan Silverberg, an assistant professor at Northwestern University Feinberg School of Medicine in Chicago.
“Either way, this condition can take a real toll on them,” added Dr Silverberg, who is also a director of Northwestern’s Multidisciplinary Eczema Center. Some people mistakenly regard eczema as a childhood disease and not a serious health problem for adults, he said.
“People who aren’t familiar with the disease might say, ‘It’s just eczema.’ But for many patients, it’s not ‘just eczema’. It can be debilitating,” Dr Silverberg said in a news release from the American Academy of Dermatology.
The intense itching and dry, red patches of skin can make daily tasks and physical activities difficult, he said. Some evidence suggests it leads to poorer job performance, disrupts sleep, and contributes to mental health problems such as anxiety and depression, he explained.
Eczema is not contagious
Also, someone with visible eczema may feel social stigma if others incorrectly believe the disease is contagious or associated with poor hygiene, Dr Silverberg said.
“Fortunately for patients, treatment can help alleviate the negative effects of this disease and improve their physical and mental well-being,” he added.
Treatment regimens include topical steroids, moisturisers, phototherapy or systemic medications.
Also, the US Food and Drug Administration recently approved two new eczema treatments: an anti-inflammatory topical medication for mild to moderate conditions and an injectable drug for tougher cases, according to Dr Silverberg.